Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Region Vaesterbotten
Sponsor

Region Vaesterbotten

Sweden Koksvagen 11, Alidhem, 907 37 Umea, Sweden

About the sponsor

Clinical research in prostate cancer is centered on advanced management of metastatic hormone-sensitive disease, with interest in PSMA-positive patient populations and treatment selection. The portfolio also includes work on the use of PSMA-PET and mpMRI to identify and define clinically relevant intraprostatic lesions.

  • Radioligand therapy in metastatic prostate cancer
  • Androgen receptor-targeted therapy comparisons
  • PSMA-PET and mpMRI lesion detection

These studies reflect a focus on improving disease control and refining diagnostic precision in prostate oncology.

About Specializations

Region Vaesterbotten runs clinical trials in conditions such as Prostate cancer, Vestibular disorder, Dengue fever, Cerebrospinal fluid circulation disorder, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

10 clinical trials

Prostate cancer

Recruiting

Study of How Enzalutamide and Apalutamide Affect Dexamethasone Processing in the Body in Patients with Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Region Vaesterbotten

Vestibular disorder

Recruiting

A Study of Prednisolone Compared to Placebo for Patients with Vestibular Neuritis to Evaluate Effects on Balance and Dizziness Symptoms

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Region Vaesterbotten

Dengue fever

Recruiting

Study on the Effects of the Dengue Vaccine Qdenga on Antibody Levels in Swedish Travelers

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Region Vaesterbotten

Cerebrospinal fluid circulation disorder

Recruiting

Study on Gadobutrol for Patients with Idiopathic Normal Pressure Hydrocephalus to Understand Cerebrospinal Fluid Movement Using MRI

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Flutemetamol (18F)
  • Sponsor:Region Vaesterbotten

General anaesthesia

Recruiting

Study on Low Oxygen and Nitrous Oxide Use During Anesthesia for Surgery Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nitrous Oxide
  • Sponsor:Region Vaesterbotten

Prostate cancer

Recruiting

Study on the Use of 18F-PSMA-1007, Hyoscine Butylbromide, and Gadoteric Acid in Imaging for Patients with High-Risk Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gadoteric Acid
  • Sponsor:Region Vaesterbotten

Prostate cancer

Recruiting

Study Comparing 177Lu-PSMA-I&T with Apalutamide, Enzalutamide, and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Region Vaesterbotten

COVID-19

Not yet recruiting

Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Region Vaesterbotten

Open angle glaucoma+1

Not recruiting

Study on Glaucoma Treatment: Comparing Brimonidine, Pilocarpine Nitrate, and Brinzolamide in Patients with Newly Diagnosed Open-Angle Glaucoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Betaxolol
  • Sponsor:Region Vaesterbotten

Rheumatoid arthritis

Not recruiting

Study on the Effectiveness and Tolerability of Oral vs. Subcutaneous Methotrexate for Patients with Early Rheumatoid Arthritis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Region Vaesterbotten

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.